Clincosm LogoSign in Get a demo

Virtual Reality Effect in Geriatric Individuals

Sponsor
Selcuk University (Other)
Overall Status
Completed
CT.gov ID
NCT04268589
Collaborator
(none)
14
Enrollment
1
Location
2
Arms
2
Actual Duration (Months)
7.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study aimed to determine the effect of a virtual reality experience on pain, depression and functional adequacy in geriatric individuals living in a nursing home.

A virtual reality video with dance moves has been applied to the experimental group participants. Each video takes 3 minutes, and the elderly person has been put into practice at least 30 minutes after having breakfast in 3-minute periods and at least 30 minutes after dinner. In the morning and evening, 15 minutes, 2 times a day, a total of 9 days were applied for 3 weeks. The application lasted a total of 3 weeks. Scales were applied 1 week after the virtual reality application was completed and 1 month after the experimental group. The scales were filled in the control group at the same time.

Condition or Disease Intervention/Treatment Phase
  • Other: virtual reality game
 N/A

Detailed Description

It is recommended that the future studies be conducted with larger samples on pain, depression, life quality and functionality.

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Supportive Care
Official Title:
Effect of Virtual Reality Application on Pain, Functional Independence and Depression in Geriatric Individuals
Actual Study Start Date :
May 1, 2019
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: control group

routine study
Experimental: virtual reality group

Three days a week, 2 times a day, 15 minutes in the morning and in the evening for 9 days in total

Other: virtual reality game
routine
Other Names:
  • routine

    		•

    Outcome Measures

    Primary Outcome Measures

    1. The visual analog scale (VAS) [nine days]

      This form includes numbers and is used in the assessment of pain severity. Patients mark their pain severity on a 10 cm ruler which is written no pain on one side and the most severe pain as possible on the other side. It has been stated that VAS is more sensitive and reliable in the measurement of pain severity than one sized scales

    2. Geriatric Depression Scale [nine days]

      The scale was developed by Yesavage with the aim of assessing the depression symptoms of old persons and consists of 15 questions in total. In the assessment, 1 point is given to each "no" answer in the positive questions and to each "yes" answer in the negative questions. A score of 6 and higher in the scale is accepted as meaningful for the diagnosis of depression. Reliability and validity tests were performed in our country and Chronbach alpha internal consistency coefficient was found to be 0.92

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Suffering from musculoskeletal pain in the last 3 years,

    • Being energetic (Being independent in the daily life activities),

    • Being able to stand up without help before 30 seconds and walk at least six meters without help,

    • Individuals with blood sugar ranging between 90-200 mg/dl prior to the application,

    • Individuals with blood pressure ranging between 130-70 mm/Hg prior to the application,

    • Not having neurological and psychiatric diseases,

    • No history of fall,

    • Being literate,

    • Not being visually-hearing impaired,

    • Being able to communicate verbally.

    Exclusion Criteria:

    • Pependent patients

    • Patients with psychiatric illness

    • Patients with joint pain disease diagnosis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Osmangazi University Eskişehir Turkey

    Sponsors and Collaborators

    • Selcuk University

    Investigators

    • Principal Investigator: Gamze Unver, Kutahya University of Health Sciences
    • Principal Investigator: Halil Ibrahim Tuna, Selcuk University
    • Principal Investigator: Guler Balci Alparslan, Osmangazi University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Halil İbrahim Tuna, Director, Selcuk University
    ClinicalTrials.gov Identifier:
    NCT04268589
    Other Study ID Numbers:
    • OGUU
    First Posted:
    Feb 13, 2020
    Last Update Posted:
    Feb 17, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Halil İbrahim Tuna, Director, Selcuk University
    geriatric pain
    geriatric depression
    Additional relevant MeSH terms:
    Depression
    Depressive Disorder

    Study Results

    No Results Posted as of Feb 17, 2020